abstract |
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts. These compounds can act as potential MEK inhibitors in the treatment of hyperproliferative diseases such as cancer and inflammation. The present invention also discloses their preparation method. <Formula I> |